Literature DB >> 13437303

The comparative utilization of uracil-2-C14 by liver, intestinal mucosa, and Flexner-Jobling carcinoma in the rat.

C HEIDELBERGER, K C LEIBMAN, E HARBERS, P M BHARGAVA.   

Abstract

Entities:  

Keywords:  INTESTINES/metabolism; LIVER/metabolism; NEOPLASMS/metabolism; URACIL/metabolism

Mesh:

Substances:

Year:  1957        PMID: 13437303

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  9 in total

1.  A clinical study of 5-fluorouracil in a variety of far advanced human malignancies.

Authors:  J E WHITE; W N RICKETTS; W J STRUDWICK
Journal:  J Natl Med Assoc       Date:  1962-05       Impact factor: 1.798

2.  Uptake in vitro of nucleic acid precursors and nucleic acids by Zajdela ascitic hepatoma cells.

Authors:  P M Bhargava; D Szafarz; C A Bornecque; F Zajdela
Journal:  J Membr Biol       Date:  1975-07-24       Impact factor: 1.843

Review 3.  [Mechanisms of pharmacologic intervention in the vital functions of the cell].

Authors:  H Herken
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1967

4.  Chemotherapy for early-stage breast cancer: a brief history.

Authors:  M Verrill
Journal:  Br J Cancer       Date:  2009-09       Impact factor: 7.640

5.  METABOLISM OF TISSUE CELLS IN SUSPENSION. SYNTHESIS OF RIBONUCLEIC ACID BY LEIVER CELLS IN SUSPENSION.

Authors:  S T JACOB; P M BHARGAVA
Journal:  Biochem J       Date:  1965-05       Impact factor: 3.857

6.  Anabolism versus catabolism of [5-3H]uridine and its relationship to ribonucleic acid labelling in mouse liver after partial hepatectomy.

Authors:  T Yngner; C Engelbrecht; L Lewan; J E Annerfeldt
Journal:  Biochem J       Date:  1979-01-15       Impact factor: 3.857

Review 7.  Participation of DNA repair in the response to 5-fluorouracil.

Authors:  M D Wyatt; D M Wilson
Journal:  Cell Mol Life Sci       Date:  2009-03       Impact factor: 9.261

8.  XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center.

Authors:  Franco M Muggia; Godefridus J Peters; Joseph R Landolph
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

9.  The value of fluorinated pyrimidines in advanced malignancy.

Authors:  J J Fennelly; M X Fitzgerald
Journal:  Br J Cancer       Date:  1968-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.